Human parechovirus
Parechovirus (respiratory panel); Human parechovirus (gastrointestinal panel)
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
RNA viruses related to enteroviruses; important in young infants.
Infections
Sepsis-like illness and meningoencephalitis in infants; mild respiratory or gastrointestinal illness in older children.
Signs and symptoms
Fever, irritability, rash; poor feeding in infants.
Antibiotic and antimicrobial resistance
No antiviral is used, so drug resistance is not a clinical issue. Antibiotics do not act on viruses; identifying a viral cause can support withholding them.
Treatment considerations
Supportive care; young infants with fever are evaluated promptly and often admitted. No antiviral is approved. Identifying parechovirus as the cause can allow antibiotics to be stopped.
Sources
- CDC, Emerging Infectious Diseases. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies (2019).
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.